These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Control of protein degradation in muscle by prostaglandins, Ca2+, and leukocytic pyrogen (interleukin 1). Goldberg AL, Baracos V, Rodemann P, Waxman L, Dinarello C. Fed Proc; 1984 Apr; 43(5):1301-6. PubMed ID: 6323220 [Abstract] [Full Text] [Related]
5. Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes. Dinarello CA, Clowes GH, Gordon AH, Saravis CA, Wolff SM. J Immunol; 1984 Sep; 133(3):1332-8. PubMed ID: 6611371 [Abstract] [Full Text] [Related]
6. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Pang L, Knox AJ. Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403 [Abstract] [Full Text] [Related]
7. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. Alleva DG, Burger CJ, Elgert KD. J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239 [Abstract] [Full Text] [Related]
8. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. Wanidworanun C, Strober W. J Immunol; 1993 Dec 15; 151(12):6853-61. PubMed ID: 8258695 [Abstract] [Full Text] [Related]
9. Human monocyte or recombinant interleukin 1's are specific for the secretion of a metalloproteinase from chondrocytes. Schnyder J, Payne T, Dinarello CA. J Immunol; 1987 Jan 15; 138(2):496-503. PubMed ID: 3098847 [Abstract] [Full Text] [Related]
10. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Moldawer LL, Svaninger G, Gelin J, Lundholm KG. Am J Physiol; 1987 Dec 15; 253(6 Pt 1):C766-73. PubMed ID: 3501247 [Abstract] [Full Text] [Related]
11. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes. Seldon PM, Barnes PJ, Giembycz MA. Cell Biochem Biophys; 1998 Dec 15; 29(1-2):179-201. PubMed ID: 9631245 [Abstract] [Full Text] [Related]
12. A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha. Seckinger P, Williamson K, Balavoine JF, Mach B, Mazzei G, Shaw A, Dayer JM. J Immunol; 1987 Sep 01; 139(5):1541-5. PubMed ID: 3040855 [Abstract] [Full Text] [Related]
13. A human IL-1 alpha derivative which lacks prostaglandin E2 inducing activity and inhibits the activity of IL-1 through receptor competition. Yamayoshi M, Ohue M, Kawashima H, Kotani H, IIda M, Kawata S, Yamada M. Lymphokine Res; 1990 Sep 01; 9(3):405-13. PubMed ID: 2169012 [Abstract] [Full Text] [Related]
14. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network. Castor CW, Smith EM, Bignall MC, Hossler PA. J Rheumatol; 1997 Nov 01; 24(11):2080-9. PubMed ID: 9375864 [Abstract] [Full Text] [Related]
15. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. Hahn G, Stuhlmüller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR. J Clin Invest; 1993 Mar 01; 91(3):862-70. PubMed ID: 8450066 [Abstract] [Full Text] [Related]
16. Interleukin-1 beta production in the rabbit brain during endotoxin-induced fever. Nakamori T, Morimoto A, Yamaguchi K, Watanabe T, Murakami N. J Physiol; 1994 Apr 01; 476(1):177-86. PubMed ID: 8046632 [Abstract] [Full Text] [Related]
17. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Taupin V, Gogusev J, Descamps-Latscha B, Zavala F. Mol Pharmacol; 1993 Jan 01; 43(1):64-9. PubMed ID: 8380885 [Abstract] [Full Text] [Related]
18. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages. Avni D, Goldsmith M, Ernst O, Mashiach R, Tuntland T, Meijler MM, Gray NS, Rosen H, Zor T. Immunol Lett; 2009 Mar 24; 123(1):1-8. PubMed ID: 19185589 [Abstract] [Full Text] [Related]
19. Dissimilarities between purified human interleukin-1 and recombinant human interleukin-2 in the induction of fever, brain prostaglandin, and acute-phase protein synthesis. Mier JW, Souza LM, Allegretta M, Boone T, Bernheim HA, Dinarello CA. J Biol Response Mod; 1985 Feb 24; 4(1):35-45. PubMed ID: 3872345 [Abstract] [Full Text] [Related]
20. Regulation of B cell tolerance by macrophage-derived mediators: antagonistic effects of prostaglandin E2 and interleukin 1. Goldings EA. J Immunol; 1986 Feb 01; 136(3):817-22. PubMed ID: 2416834 [Abstract] [Full Text] [Related] Page: [Next] [New Search]